| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,302 |
4,040 |
$701K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,405 |
2,276 |
$452K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
589 |
564 |
$209K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
302 |
289 |
$196K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,007 |
952 |
$87K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
100 |
97 |
$52K |
| 70450 |
Computed tomography, head or brain; without contrast material |
194 |
191 |
$34K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,201 |
1,132 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
843 |
775 |
$1K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
114 |
106 |
$352.92 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
570 |
552 |
$246.08 |
| 80053 |
Comprehensive metabolic panel |
1,934 |
1,758 |
$88.57 |
| 71045 |
Radiologic examination, chest; single view |
695 |
672 |
$85.27 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
601 |
571 |
$66.88 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,963 |
1,840 |
$52.37 |
| 71046 |
Radiologic examination, chest; 2 views |
524 |
515 |
$27.21 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,100 |
1,034 |
$23.68 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
314 |
312 |
$19.58 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
872 |
800 |
$18.28 |
| 36415 |
Collection of venous blood by venipuncture |
2,030 |
1,910 |
$15.60 |
| 84484 |
|
465 |
435 |
$15.17 |
| 82553 |
|
234 |
215 |
$10.03 |
| 81003 |
|
1,046 |
997 |
$9.06 |
| 81025 |
|
695 |
671 |
$8.34 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
75 |
72 |
$5.59 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
448 |
434 |
$0.17 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
177 |
168 |
$0.03 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
59 |
56 |
$0.00 |
| 87631 |
|
340 |
334 |
$0.00 |
| 84702 |
|
55 |
55 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
252 |
246 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
116 |
114 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
12 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
969 |
925 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
25 |
24 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
298 |
287 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
13 |
$0.00 |
| J3490 |
Unclassified drugs |
383 |
355 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
145 |
119 |
$0.00 |
| 87428 |
|
40 |
40 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
181 |
177 |
$0.00 |